Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek Stewart

Showing results (321-330 of 330) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 330 results.
Nature Communications|April 6, 2023
Genipin prevents alpha-synuclein aggregation and toxicity by affecting endocytosis, metabolism and lipid storageRita Rosado-Ramos, Gonçalo M Poças, Daniela Marques, et al.
Trials|October 17, 2019
What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) studyDan Brunsdon, Linda Biesty, Peter Brocklehurst, et al.
Plos One|April 19, 2018
A case study of polypharmacy management in nine European countries: Implications for change management and implementationJennifer McIntosh, Albert Alonso, Katie MacLure, et al.
Frontiers in Pharmacology|August 21, 2023
Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomesKamila Urbańczyk, Sonja Guntschnig, Vasilis Antoniadis, et al.
Trials|March 2, 2018
Identifying trial recruitment uncertainties using a James Lind Alliance Priority Setting Partnership - the PRioRiTy (Prioritising Recruitment in Randomised Trials) studyPatricia Healy, Sandra Galvin, Paula R Williamson, et al.
Plant Physiology|November 7, 2018
Identification and Microbial Production of the Raspberry Phenol Salidroside that Is Active against Huntington's DiseaseNicolai Kallscheuer, Regina Menezes, Alexandre Foito, et al.
BMJ (Clinical Research Ed.)|May 21, 2026
CRT-Estimands Framework: consensus based extension of the ICH E9(R1) addendum for cluster randomised trialsBrennan C Kahan, Frank Bretz, Andrew Copas, et al.
BMJ (Clinical Research Ed.)|July 9, 2024
Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaborationAnthony Muchai Manyara, Philippa Davies, Derek Stewart, et al.
BMJ (Clinical Research Ed.)|July 9, 2024
Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaborationAnthony Muchai Manyara, Philippa Davies, Derek Stewart, et al.
Eclinicalmedicine|October 25, 2023
A framework for the definition and interpretation of the use of surrogate endpoints in interventional trialsOriana Ciani, Anthony M Manyara, Philippa Davies, et al.
Pageof 33

Showing results (321-330 of 330) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 330 results.
Nature Communications|April 6, 2023
Genipin prevents alpha-synuclein aggregation and toxicity by affecting endocytosis, metabolism and lipid storageRita Rosado-Ramos, Gonçalo M Poças, Daniela Marques, et al.
Trials|October 17, 2019
What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) studyDan Brunsdon, Linda Biesty, Peter Brocklehurst, et al.
Plos One|April 19, 2018
A case study of polypharmacy management in nine European countries: Implications for change management and implementationJennifer McIntosh, Albert Alonso, Katie MacLure, et al.
Frontiers in Pharmacology|August 21, 2023
Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomesKamila Urbańczyk, Sonja Guntschnig, Vasilis Antoniadis, et al.
Trials|March 2, 2018
Identifying trial recruitment uncertainties using a James Lind Alliance Priority Setting Partnership - the PRioRiTy (Prioritising Recruitment in Randomised Trials) studyPatricia Healy, Sandra Galvin, Paula R Williamson, et al.
Plant Physiology|November 7, 2018
Identification and Microbial Production of the Raspberry Phenol Salidroside that Is Active against Huntington's DiseaseNicolai Kallscheuer, Regina Menezes, Alexandre Foito, et al.
BMJ (Clinical Research Ed.)|May 21, 2026
CRT-Estimands Framework: consensus based extension of the ICH E9(R1) addendum for cluster randomised trialsBrennan C Kahan, Frank Bretz, Andrew Copas, et al.
BMJ (Clinical Research Ed.)|July 9, 2024
Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaborationAnthony Muchai Manyara, Philippa Davies, Derek Stewart, et al.
BMJ (Clinical Research Ed.)|July 9, 2024
Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaborationAnthony Muchai Manyara, Philippa Davies, Derek Stewart, et al.
Eclinicalmedicine|October 25, 2023
A framework for the definition and interpretation of the use of surrogate endpoints in interventional trialsOriana Ciani, Anthony M Manyara, Philippa Davies, et al.
Pageof 33